（S）-2-（2,4-二氧-四氢嘧啶-1-基）-3-甲基丁酸,(S)-2-(2,4-Dioxo-tetrahydropyrimidin-1-yl)-3-methylbutyric Acid,CAS：192725-86-6

(4-氯-3-(4-乙氧基苄基)苯基)((3AS,5R,6S,6AS)-6-羟基-2,2-二甲基四氢呋喃并[2,3-d] [1,3]二氧杂环戊烯-5-基)甲酮 1103738-30-2

(2S,4R)-N-{(1S)-2-羟基-1-[(2S,3R,4S,5R,6R)-3,4,5-三羟基-6-(甲硫基)-四氢-2H-2-吡喃基]丙基}-1-甲基-4-丙基吡咯烷-2-甲酰胺盐酸盐

(S)N2,N6-双丙酰胺基-4,5,6,7-四氢-1,3-苯并噻唑

（1S，3R）-2-（2-氯乙酰基）-2，3，4，9-四氢-1- [4-（甲氧基羰基）苯基] -1H-吡啶并[3，4-b]吲哚-3-羧酸 酸甲酯

(S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1螺二氢茚1040274-10-9

(2S)​-1-​(11bS)​-​联萘[2，​1-​d:1'，​2'-​f]​[1，​3，​2]​二氧磷杂-​4-​基-​1，​2，​3，​4-​四氢-​2-​甲基喹*啉

CAS:376608-65-0,2-[[(3aR,4S,6R,6aS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐价格

18881-17-9/ (S)-1,2,3,4-四氢异啉-3-基-甲醇 ,98%

2-丁基(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸甲酯,910129-15-6

(S)-N-(1-((R)-1,2,3,4-四氢萘基)甲基)-3-奎宁胺

(S)-(+)-1,2,3,4-Tetrahydro-1-naphthylamine(S)-(+)-1,2,3,4-四氢-1-萘胺, ee: 98%

(S)-1-苯基-1,2,3,4-四氢异喹啉，98%

4-氨基-5-乙炔基-1-((2R,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基)嘧啶-2(1H)-酮

(1R,3S,4R,5S)-1,3,4-trihydroxy-5-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-cyclohexane-1-carboxylic acid 5746-55-4

2-((3AR,4S,6R,6AS)-6-氨基-2,2-甲基四氢-3AH-环戊基[D] [1,3]并二氧-4-氧)乙醇

盐酸左旋咪唑/(S)-6-苯基-2,3,5,6-四氢-咪唑(2,1-B)噻唑单盐酸盐/左旋咪唑/L-2,3,5,6-四氢-6-苯基(2,1-B)噻唑盐酸盐/左咪唑/左旋四唑/驱虫速/(S)-(-)-6-苯基-2,3,5,6-四氢咪唑并[2,1-b]噻唑盐酸盐/左旋四咪唑/Levamisole hydrochloride

CAS:816456-90-3标准品(4AS，7S)-5，6，7，8-四氢-7-羟基-7-(1-羟基-1-甲基乙基)-1，4A-二甲基-2(4AH)-萘酮

(S)-2，3，9，10-四氢-5-羟基-8，8-二甲基-2-苯基-4H，8H-苯并[1，2-B:3，4-B’]二吡喃-4-酮

(S)-N-((3,4-Dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylacetamide

(4S)-1-(Methyl-d3)-2-oxo-?4-imidazolidinecarboxylic Acid?, tert-Butyl Ester

AT13148 是一种可口服的，ATP 竞争性的 AGC kinase 的抑制剂，能够抑制 Akt1/Akt2/Akt3，p70S6K，PKA 和 ROCKI/ROCKII 的活性，IC50 值分别为 38 nM/402 nM/50 nM，8 nM，3 nM 和 6 nM/4 nM。

(2S)-1-(11bS)-联萘[2,1-d:1',2'-f][1,3,2]二氧磷杂-4-基-1,2,3,4-四氢-2-甲基喹

(S)-(-)-2,6-二氨基-4,5,6,7-四氢苯并噻唑 106092-09-5，1g

(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide，orb1819251，Biorbyt

192725-50-1 /(2S)-(1-四氢嘧啶-2-酮)-3-甲基丁酸

(1R,4S)-1,3,3-三甲基二环[2,2,1]庚烷-2-酮

(3S)-4-[[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-[[(2S)-1-[(2S)-3-hydroxy-2-[[(2S)-2-[[(2S,3R)-3-hydroxy-2-[[(2S)-4-methyl-2-[[(2S)-5-oxopyrrolidine-2-carbonyl

N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine-d3

(S,S)-(+)-2,3-二甲氧基-1,4-双(二甲氨基)丁烷

elF2 alpha (EIF2S1) Mouse Monoclonal Antibody [Clone ID: LBI3H4]

Ptd(S)Ins-(3,4)-P2 (1,2-dioctanoyl) (sodium salt)

2-((S)-Quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline

(S)-3,4-二氢-4-羟基-2-(3-甲氧丙基)-2H-噻吩并[3,2-E]-1,2-噻嗪-6-磺酰胺 1,1-二氧化物

B3295-10MG SIGMA 1H-Thieno[3,4-d]imidazole-4-pentanamide,N-[6-[[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]amino]-6-oxohexyl]hexahydro-2-oxo-,(3aS,4S,6aR)-

中检院所标准品喹那普利杂质Ⅰ[3S-[2(R*),3a,11aβ]]-1,3,4,6,11,11a-六氢-3-甲基-1,4-二氧代-α-（2-苯乙基）-2H-吡嗪并[1,2-b]异喹啉-2-乙酸乙酯

Cholera Autoinducer 1: (3S)-3-Hydroxy-4-tridecanone，C13H26O2

N-(9-((2R,3R,4R,5R)-4-((tert-butyldimethylsilyl)oxy)-5-((S)-2-cyclopropyl-1-hydroxyethyl)-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide

(S)-(+)-2,3,7,7a-四氢-7a-甲基-1H-茚-1,5(6H)-二酮 / (S)-(+)-2,3,7,7a-四氢-7a-甲基-1H-茚-1,5(6H)-二酮 97%

Anti-RSK1 / 2 / 3 / 4 (Phospho-Ser221 / 227 / S218 / 232) Antibody (A50659)